Chetan Brahma Kammari, MD | |
201 E Grover St, Shelby, NC 28150-3917 | |
(980) 487-3678 | |
Not Available |
Full Name | Chetan Brahma Kammari |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 15 Years |
Location | 201 E Grover St, Shelby, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588928824 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 2017-00551 (North Carolina) | Secondary |
207R00000X | Internal Medicine | 2017-00551 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Atrium Health Cleveland | Shelby, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Carolinas Physicians Network Inc | 3375449655 | 1613 |
News Archive
New guidance has been released today by the National Institute for Health and Care Excellence (NICE) recommending Olympus Medical's transurethral resection in saline (TURis) system for use in surgery to reduce the size of enlarged prostate glands in men. NICE published the guidance in light of the potential it offers NHS hospitals to realise substantial cost savings of £285-£375 per patient whilst also improving patient outcomes.
Successive, vigorous bouts of leg compressions following a stroke appear to trigger natural protective mechanisms that reduce damage, researchers report.
"During the month of May, USAID's "IMPACTblog" "will be highlighting USAID's work in Global Health," the blog notes, adding, "From May 1-10, we will be featuring the role that science, technology and innovation plays in global health."
GlaxoSmithKline and Human Genome Sciences, Inc. announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion, recommending marketing authorisation for BENLYSTA (belimumab) as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus, with a high degree of disease activity, despite standard therapy.
› Verified 6 days ago
Entity Name | Carolinas Physicians Network Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477878890 PECOS PAC ID: 3375449655 Enrollment ID: O20031219000455 |
News Archive
New guidance has been released today by the National Institute for Health and Care Excellence (NICE) recommending Olympus Medical's transurethral resection in saline (TURis) system for use in surgery to reduce the size of enlarged prostate glands in men. NICE published the guidance in light of the potential it offers NHS hospitals to realise substantial cost savings of £285-£375 per patient whilst also improving patient outcomes.
Successive, vigorous bouts of leg compressions following a stroke appear to trigger natural protective mechanisms that reduce damage, researchers report.
"During the month of May, USAID's "IMPACTblog" "will be highlighting USAID's work in Global Health," the blog notes, adding, "From May 1-10, we will be featuring the role that science, technology and innovation plays in global health."
GlaxoSmithKline and Human Genome Sciences, Inc. announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion, recommending marketing authorisation for BENLYSTA (belimumab) as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus, with a high degree of disease activity, despite standard therapy.
› Verified 6 days ago
Entity Name | Apogee Medical Group Ohio Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477500999 PECOS PAC ID: 8224082292 Enrollment ID: O20050311000733 |
News Archive
New guidance has been released today by the National Institute for Health and Care Excellence (NICE) recommending Olympus Medical's transurethral resection in saline (TURis) system for use in surgery to reduce the size of enlarged prostate glands in men. NICE published the guidance in light of the potential it offers NHS hospitals to realise substantial cost savings of £285-£375 per patient whilst also improving patient outcomes.
Successive, vigorous bouts of leg compressions following a stroke appear to trigger natural protective mechanisms that reduce damage, researchers report.
"During the month of May, USAID's "IMPACTblog" "will be highlighting USAID's work in Global Health," the blog notes, adding, "From May 1-10, we will be featuring the role that science, technology and innovation plays in global health."
GlaxoSmithKline and Human Genome Sciences, Inc. announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion, recommending marketing authorisation for BENLYSTA (belimumab) as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus, with a high degree of disease activity, despite standard therapy.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Chetan Brahma Kammari, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Chetan Brahma Kammari, MD 201 E Grover St, Shelby, NC 28150-3917 Ph: (980) 487-3678 |
News Archive
New guidance has been released today by the National Institute for Health and Care Excellence (NICE) recommending Olympus Medical's transurethral resection in saline (TURis) system for use in surgery to reduce the size of enlarged prostate glands in men. NICE published the guidance in light of the potential it offers NHS hospitals to realise substantial cost savings of £285-£375 per patient whilst also improving patient outcomes.
Successive, vigorous bouts of leg compressions following a stroke appear to trigger natural protective mechanisms that reduce damage, researchers report.
"During the month of May, USAID's "IMPACTblog" "will be highlighting USAID's work in Global Health," the blog notes, adding, "From May 1-10, we will be featuring the role that science, technology and innovation plays in global health."
GlaxoSmithKline and Human Genome Sciences, Inc. announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion, recommending marketing authorisation for BENLYSTA (belimumab) as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus, with a high degree of disease activity, despite standard therapy.
› Verified 6 days ago
Renee B. Melton-smith, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 807 Schenck St, Ste 2, Shelby, NC 28150 Phone: 980-487-2540 | |
Kyle Anthony Aldinger, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 711 N Dekalb St, Shelby, NC 28150 Phone: 704-482-1482 Fax: 704-480-6012 | |
Osaguona Osa, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 E Grover St, Shelby, NC 28150 Phone: 980-487-3678 Fax: 980-487-2222 | |
Paul Brent Ferrell, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 711 N Dekalb St, Shelby, NC 28150 Phone: 704-482-1482 Fax: 704-480-6012 | |
Aamir Iqbal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 711 N Dekalb St, Shelby, NC 28150 Phone: 704-482-1482 | |
Forrest Leigh Thompson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 E Grover St, Shelby, NC 28150 Phone: 980-487-2600 | |
Donnielle Lynn Green, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 951 Wendover Height Dr, Shelby, NC 28150 Phone: 704-487-4677 Fax: 704-887-6450 |